课题基金 / 基金详情

THE ADAPT HYPERTENSION STUDY

THE ADAPT HYPERTENSION STUDY
适应高血压研究
批准号:
7380487
负责人:
Jamy D Ard
金额:
$1.29万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2007-02-28
关键词:

项目摘要

项目成果

Jamy D Ard的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Hypertension is both more common and more severe in African-Americans compared with Whites. The Dietary Approaches to Stop Hypertension (DASH) dietary pattern was proven to reduce hypertension in a randomized trial, and the effect was greatest for African-Americans. However, when translated into the real world, an effectiveness study of the DASH pattern revealed only modest blood pressure lowering benefit for African-Americans and no benefit for African American women, in particular. Using principles of formative analysis, we have developed a modified DASH dietary pattern intervention that is expected to be culturally appropriate for African-Americans. The primary aim for this study is to conduct a randomized, controlled trial to determine the effectiveness of the modified DASH dietary pattern in reducing blood pressure for a cohort of African-Americans with pre-hypertension or stage I hypertension compared to a usual care control group. We hypothesize that greater blood pressure reduction will be achieved using a culturally appropriate DASH diet intervention in a group of African-Americans with prehypertension to stage I hypertension compared to a usual care control group. Primary outcomes are change in systolic and diastolic BP at 6 months. Secondary outcomes include changes in fruit, vegetable, dairy, and fat intake.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery
  • 批准号:
    10440068
  • 项目类别:
  • 资助金额:
    $66.08万
  • 财政年份:
    2022
  • 负责人:
    Jamy D Ard
  • 依托单位:
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery
  • 批准号:
    10624846
  • 项目类别:
  • 资助金额:
    $64.43万
  • 财政年份:
    2022
  • 负责人:
    Jamy D Ard
  • 依托单位:
1/2, Clinical Coordinating Center for the Long-term Effectiveness of the Anti-obesity medication Phentermine: the LEAP Trial
1/2, Clinical Coordinating Center for the Long-term Effectiveness of the Anti-obesity medication Phentermine: the LEAP Trial
海外基金